BIOTON Balance Sheet Health
Financial Health criteria checks 6/6
BIOTON has a total shareholder equity of PLN595.2M and total debt of PLN40.8M, which brings its debt-to-equity ratio to 6.8%. Its total assets and total liabilities are PLN790.4M and PLN195.2M respectively.
Key information
6.8%
Debt to equity ratio
zł40.77m
Debt
| Interest coverage ratio | n/a |
| Cash | zł623.00k |
| Equity | zł595.22m |
| Total liabilities | zł195.20m |
| Total assets | zł790.42m |
Financial Position Analysis
Short Term Liabilities: BIO's short term assets (PLN150.7M) exceed its short term liabilities (PLN143.9M).
Long Term Liabilities: BIO's short term assets (PLN150.7M) exceed its long term liabilities (PLN51.3M).
Debt to Equity History and Analysis
Debt Level: BIO's net debt to equity ratio (6.7%) is considered satisfactory.
Reducing Debt: BIO's debt to equity ratio has reduced from 21.7% to 6.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable BIO has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: BIO is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 27.4% per year.